ATE374023T1 - Pharmazeutische zusammensetzungen enthaltend mycophenolsäure oder ein mycophenolat salz - Google Patents

Pharmazeutische zusammensetzungen enthaltend mycophenolsäure oder ein mycophenolat salz

Info

Publication number: ATE374023T1
Authority: AT; Austria
Prior art keywords: pharmaceutical compositions; compositions containing; mycophenolic acid; mycophenolate salt; containing mycophenolic
Prior art date: 2001-10-17

Application number

AT02777314T

Other languages

English (en)

Inventor

Juergen Dederichs

Thomas Rigassi

Original Assignee

Novartis Pharma Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-17

Filing date

2002-10-16

Publication date

2007-10-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9924043&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE374023(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-10-16 Application filed by Novartis Pharma Ag filed Critical Novartis Pharma Ag

2007-10-15 Application granted granted Critical

2007-10-15 Publication of ATE374023T1 publication Critical patent/ATE374023T1/de

Links

HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical compound OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 title 2
HPNSFSBZBAHARI-UHFFFAOYSA-N micophenolic acid Natural products OC1=C(CC=C(C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-UHFFFAOYSA-N 0.000 title 1
229960000951 mycophenolic acid Drugs 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Transplantation (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Furan Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

AT02777314T 2001-10-17 2002-10-16 Pharmazeutische zusammensetzungen enthaltend mycophenolsäure oder ein mycophenolat salz ATE374023T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0124953.1A GB0124953D0 (en)	2001-10-17	2001-10-17	Organic Compounds

Publications (1)

Publication Number	Publication Date
ATE374023T1 true ATE374023T1 (de)	2007-10-15

Family

ID=9924043

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02777314T ATE374023T1 (de)	2001-10-17	2002-10-16	Pharmazeutische zusammensetzungen enthaltend mycophenolsäure oder ein mycophenolat salz

Country Status (31)

Country	Link
US (3)	US20050013859A1 (de)
EP (1)	EP1438040B2 (de)
JP (2)	JP2005508959A (de)
KR (1)	KR100671367B1 (de)
CN (1)	CN1310640C (de)
AR (2)	AR036813A1 (de)
AT (1)	ATE374023T1 (de)
AU (1)	AU2002338897B2 (de)
BR (1)	BR0213355A (de)
CA (1)	CA2460574A1 (de)
CO (1)	CO5390076A1 (de)
CY (1)	CY1107841T1 (de)
DE (1)	DE60222687T3 (de)
DK (1)	DK1438040T4 (de)
EC (2)	ECSP024341A (de)
ES (1)	ES2292819T5 (de)
GB (1)	GB0124953D0 (de)
HU (1)	HU231114B1 (de)
IL (2)	IL160968A0 (de)
MX (1)	MXPA04003636A (de)
MY (1)	MY139206A (de)
NO (1)	NO341804B1 (de)
NZ (1)	NZ532280A (de)
PE (1)	PE20030476A1 (de)
PL (2)	PL415001A1 (de)
PT (1)	PT1438040E (de)
RU (2)	RU2338528C2 (de)
SI (1)	SI1438040T2 (de)
TW (1)	TWI333861B (de)
WO (1)	WO2003032978A1 (de)
ZA (1)	ZA200401977B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0124953D0 (en)	2001-10-17	2001-12-05	Novartis Ag	Organic Compounds
AR045957A1 (es) *	2003-10-03	2005-11-16	Novartis Ag	Composicion farmaceutica y combinacion
TWI322147B (en) *	2004-07-20	2010-03-21	Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag	Crystalline mycophenolate sodium
GB0419355D0 (en) *	2004-08-31	2004-09-29	Novartis Ag	Organic compounds
WO2006086498A2 (en) *	2005-02-08	2006-08-17	Aspreva Pharmaceuticals Sa	Treatment of vascular, autoimmune and inflammatory diseases using low dosages of impdh inhibitors
EP1917010A2 (de) *	2005-02-08	2008-05-07	Aspreva Pharmaceuticals SA	Zusammensetzungen und verfahren zur behandlung von gefäss-, autoimmun- und entzündlichen erkrankungen
EP1940388A2 (de) *	2005-09-30	2008-07-09	Novartis AG	Dpp iv-hemmer zur verwendung bei der behandlung von autoimmunkrankheiten und transplantatabstossung
US8597679B2 (en)	2005-12-21	2013-12-03	Basf Se	Fine-particle crosslinked polyvinylpyrrolidone as tablet disintegrant
KR20080094788A (ko) *	2006-02-13	2008-10-24	노파르티스 아게	고복용량의 미코페놀산(엠피에이)
EP2164460B1 (de)	2007-06-06	2017-08-09	Basf Se	Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten
EP2164462B1 (de)	2007-06-06	2017-05-31	Basf Se	Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten
AU2008288106B2 (en) *	2007-08-13	2012-03-15	Panacea Biotec Limited	Extended release compositions comprising mycophenolate sodium and processes thereof
CN101969931A (zh) *	2008-03-05	2011-02-09	万能药生物有限公司	包含霉酚酸的调节释放药物组合物及其方法
JP2011527339A (ja) *	2008-07-09	2011-10-27	アスプレバインターナショナルリミテッド	眼障害を処置するためのミコフェノール酸ナトリウムのｐＨ特異的な溶液
US20110086102A1 (en) *	2009-10-13	2011-04-14	Teva Pharmaceutical Industries Ltd.	Delayed release compositions
EA201270544A1 (ru) *	2009-10-13	2012-09-28	Тева Фармасьютикал Индастриз Лтд.	Композиции с отсроченным высвобождением
WO2011051967A2 (en) *	2009-10-23	2011-05-05	Alkem Laboratories Ltd	Pharmaceutical compositions comprising mycophenolate and processes for preparing thereof
GB201100786D0 (en)	2011-01-18	2011-03-02	Ems Sa	Pharmaceutical compositions of immunosuppressants
CN102793658A (zh) *	2012-08-23	2012-11-28	无锡福祈制药有限公司	一种含有麦考酚酸或麦考酚酸盐的骨架型制剂及其包衣片
CN103845323B (zh) *	2012-11-30	2018-02-02	重庆华邦制药有限公司	麦考酚酸及其盐肠溶制剂和制备方法
WO2014167442A1 (en)	2013-03-26	2014-10-16	Wockhardt Limited	Pharmaceutical compositions comprising mycophenolic acid or salts thereof
CN106727403A (zh) *	2017-01-03	2017-05-31	无锡福祈制药有限公司	一种麦考酚钠肠溶片及其制备方法
MX2019010829A (es) *	2017-03-13	2020-02-05	Okava Pharmaceuticals Inc	Metodos y composiciones para suministrar agentes activos de acido micofenolico a mamiferos no humanos.
MY203360A (en)	2018-06-06	2024-06-26	Metavant Sciences Gmbh	Methods of treating subjects having diabetes with chronic kidney disease
CA3103324A1 (en)	2018-06-14	2019-12-19	Poxel	Film-coated tablet comprising a triazine derivative for use in the treatment of diabetes
RU2723255C2 (ru) *	2018-11-14	2020-06-09	Общество с ограниченной ответственностью "Изварино Фарма"	Экструдат с микофенолятом натрия для получения пероральной твердой лекарственной формы
US12569481B2 (en)	2020-06-12	2026-03-10	Vanderbilt University	Methods of treatment for gastrointestinal motility disorders
EP4438037A1 (de) *	2021-01-28	2024-10-02	Priothera SAS	Behandlungsverfahren mit s1p-rezeptormodulatoren
AU2021424131B2 (en) *	2021-01-28	2026-08-13	Priothera Limited	Methods of treatment with s1p receptor modulators
WO2022250977A1 (en) *	2021-05-26	2022-12-01	The Texas A&M University System	Biodegradable mucoadhesive pharmaceutical formulations and methods thereof
CN117442580B (zh) *	2023-12-21	2024-04-05	泊诺(天津)创新医药研究有限公司	一种高生物利用度麦考酚钠肠溶片及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1157100A (en) †	1966-09-27	1969-07-02	Ici Ltd	Pharmaceutical Compositions
GB1157099A (en) *	1966-09-27	1969-07-02	Ici Ltd	Fermentation Process
GB1203328A (en) *	1968-06-04	1970-08-26	Ici Ltd	Pharmaceutical compositions
US3705946A (en) *	1971-05-25	1972-12-12	Lilly Co Eli	Method of treating hyperuricemia
US3880995A (en) *	1973-05-14	1975-04-29	Lilly Co Eli	Treatment of arthritis with mycophenolic acid and derivatives
JPS56127093A (en) *	1980-03-10	1981-10-05	Ajinomoto Co Inc	Preparation of mycophenolic acid
US4725622A (en) *	1986-01-23	1988-02-16	Syntex (U.S.A.) Inc.	Mycophenolic acid derivatives in the treatment of rheumatoid arthritis
US4959387A (en) *	1986-01-23	1990-09-25	Syntex (U.S.A.) Inc.	Mycophenolic acid derivatives in the treatment of rheumatoid arthritis
US5177072A (en) *	1987-01-30	1993-01-05	Syntex (U.S.A.) Inc.	Treatment of autoimmune inflammatory, and psoriatic diseases with heterocyclic aminoalkyl esters of mycophenolic acid and derivatives
US4753935A (en) *	1987-01-30	1988-06-28	Syntex (U.S.A.) Inc.	Morpholinoethylesters of mycophenolic acid and pharmaceutical compositions
US4748173A (en) *	1987-01-30	1988-05-31	Syntex (U.S.A.) Inc.	Heterocyclic aminoalkyl esters of mycophenolic acid and derivatives thereof and pharmaceutical compositions
WO1994012184A1 (en) *	1992-11-24	1994-06-09	Syntex (U.S.A.) Inc.	Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis
EP0670724A1 (de) *	1992-11-24	1995-09-13	Syntex (U.S.A.) Inc.	Verwendung von mycophenolsäure, mycophenolate mofetil und ihre derivate zur hemmung der stenose
CN1047075C (zh) *	1993-02-26	1999-12-08	普罗克特和甘保尔公司	比沙可啶剂型
US5843479A (en) *	1993-02-26	1998-12-01	The Procter & Gamble Company	Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
US5651983A (en) *	1993-02-26	1997-07-29	The Procter & Gamble Company	Bisacodyl dosage form for colonic delivery
US5656290A (en) *	1993-02-26	1997-08-12	The Procter & Gamble Company	Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
US5455045A (en) *	1993-05-13	1995-10-03	Syntex (U.S.A.) Inc.	High dose formulations
PL177323B1 (pl) *	1993-10-01	1999-10-29	Syntex Inc	Kompozycja farmaceutyczna zawierająca mykofenolan mofetylu lub kwas mykofenolowy i sposób wytwarzania kompozycji farmaceutycznej zawierającej mykofenolan mofetylu lub kwas mykofenolowy
EP0724441A1 (de) *	1993-10-19	1996-08-07	The Procter & Gamble Company	Natriumpicosulfat enthaltende dosierungsform
US5514663A (en) *	1993-10-19	1996-05-07	The Procter & Gamble Company	Senna dosage form
US5482718A (en) *	1994-03-23	1996-01-09	Hoffmann-La Roche Inc.	Colon-targeted delivery system
US5686106A (en) *	1995-05-17	1997-11-11	The Procter & Gamble Company	Pharmaceutical dosage form for colonic delivery
ID18663A (id) *	1996-04-12	1998-04-30	Novartis Ag	Komposisi farmasi berlapis enterik
WO2000067773A2 (en) *	1999-05-10	2000-11-16	Novartis Ag	Combinations of immunosupressive agents for the treatment or prevention of graft rejections
HUP9903226A2 (en) *	1999-09-23	2002-08-28	Gyogyszerki	Process for producing mycophenolic acid and derivatives thereof
JP2003525052A (ja) *	2000-02-29	2003-08-26	バイオコン・インディア・リミテッド	マイコフェノール酸の製造および精製
GB0124953D0 (en)	2001-10-17	2001-12-05	Novartis Ag	Organic Compounds
GB0301259D0 (en)	2003-01-20	2003-02-19	Novartis Ag	Organic compounds

2001
- 2001-10-17 GB GBGB0124953.1A patent/GB0124953D0/en not_active Ceased
2002
- 2002-10-15 AR ARP020103852A patent/AR036813A1/es not_active Application Discontinuation
- 2002-10-15 TW TW091123694A patent/TWI333861B/zh not_active IP Right Cessation
- 2002-10-15 PE PE2002001013A patent/PE20030476A1/es not_active Application Discontinuation
- 2002-10-15 CO CO02092380A patent/CO5390076A1/es not_active Application Discontinuation
- 2002-10-16 ES ES02777314T patent/ES2292819T5/es not_active Expired - Lifetime
- 2002-10-16 MY MYPI20023865A patent/MY139206A/en unknown
- 2002-10-16 PL PL415001A patent/PL415001A1/pl unknown
- 2002-10-16 PT PT02777314T patent/PT1438040E/pt unknown
- 2002-10-16 IL IL16096802A patent/IL160968A0/xx unknown
- 2002-10-16 CN CNB028198611A patent/CN1310640C/zh not_active Expired - Fee Related
- 2002-10-16 EP EP02777314.2A patent/EP1438040B2/de not_active Expired - Lifetime
- 2002-10-16 US US10/492,289 patent/US20050013859A1/en not_active Abandoned
- 2002-10-16 MX MXPA04003636A patent/MXPA04003636A/es active IP Right Grant
- 2002-10-16 JP JP2003535782A patent/JP2005508959A/ja active Pending
- 2002-10-16 DK DK02777314.2T patent/DK1438040T4/da active
- 2002-10-16 RU RU2004115332/15A patent/RU2338528C2/ru not_active IP Right Cessation
- 2002-10-16 DE DE60222687.2T patent/DE60222687T3/de not_active Expired - Lifetime
- 2002-10-16 BR BRPI0213355-5A patent/BR0213355A/pt active Search and Examination
- 2002-10-16 AT AT02777314T patent/ATE374023T1/de active
- 2002-10-16 AU AU2002338897A patent/AU2002338897B2/en not_active Expired
- 2002-10-16 HU HU0600451A patent/HU231114B1/hu unknown
- 2002-10-16 WO PCT/EP2002/011589 patent/WO2003032978A1/en not_active Ceased
- 2002-10-16 PL PL367738A patent/PL234541B1/pl unknown
- 2002-10-16 KR KR1020047005588A patent/KR100671367B1/ko not_active Ceased
- 2002-10-16 SI SI200230646T patent/SI1438040T2/sl unknown
- 2002-10-16 NZ NZ532280A patent/NZ532280A/en not_active IP Right Cessation
- 2002-10-16 CA CA002460574A patent/CA2460574A1/en not_active Abandoned
- 2002-11-19 EC EC2002004341A patent/ECSP024341A/es unknown
- 2002-11-19 EC EC2002004342A patent/ECSP024342A/es unknown
2004
- 2004-03-11 ZA ZA200401977A patent/ZA200401977B/en unknown
- 2004-03-18 IL IL160968A patent/IL160968A/en active IP Right Grant
- 2004-05-03 NO NO20041785A patent/NO341804B1/no not_active IP Right Cessation
2007
- 2007-08-13 RU RU2007130786/15A patent/RU2381026C2/ru not_active IP Right Cessation
- 2007-12-19 CY CY20071101618T patent/CY1107841T1/el unknown
2009
- 2009-01-23 JP JP2009012781A patent/JP2009137996A/ja active Pending
2010
- 2010-05-03 US US12/772,608 patent/US20100210717A1/en not_active Abandoned
2012
- 2012-05-04 AR ARP120101574A patent/AR085778A2/es not_active Application Discontinuation
- 2012-05-29 US US13/482,003 patent/US20120237601A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CN1564684A (zh)	2005-01-12
TWI333861B (en)	2010-12-01
PL367738A1 (en)	2005-03-07
NO20041785L (no)	2004-05-03
IL160968A (en)	2016-04-21
DE60222687T3 (de)	2020-03-05
DE60222687T2 (de)	2008-07-17
EP1438040B2 (de)	2019-10-16
DE60222687D1 (de)	2007-11-08
ECSP024341A (es)	2003-12-01
RU2007130786A (ru)	2009-02-20
EP1438040A1 (de)	2004-07-21
IL160968A0 (en)	2004-08-31
RU2004115332A (ru)	2005-04-20
DK1438040T4 (da)	2020-01-27
PT1438040E (pt)	2008-01-02
SI1438040T2 (sl)	2020-02-28
RU2381026C2 (ru)	2010-02-10
AU2002338897B2 (en)	2006-10-19
GB0124953D0 (en)	2001-12-05
SI1438040T1 (sl)	2008-04-30
RU2338528C2 (ru)	2008-11-20
KR100671367B1 (ko)	2007-01-19
HU231114B1 (hu)	2020-09-28
PL234541B1 (pl)	2020-03-31
ES2292819T5 (es)	2020-05-29
HUP0600451A2 (en)	2006-09-28
MY139206A (en)	2009-08-28
CN1310640C (zh)	2007-04-18
PE20030476A1 (es)	2003-07-30
JP2009137996A (ja)	2009-06-25
AR085778A2 (es)	2013-10-30
JP2005508959A (ja)	2005-04-07
ES2292819T3 (es)	2008-03-16
WO2003032978A1 (en)	2003-04-24
HK1067861A1 (en)	2005-04-22
AR036813A1 (es)	2004-10-06
NO341804B1 (no)	2018-01-22
US20050013859A1 (en)	2005-01-20
MXPA04003636A (es)	2004-07-27
US20100210717A1 (en)	2010-08-19
DK1438040T3 (da)	2008-02-04
US20120237601A1 (en)	2012-09-20
NZ532280A (en)	2007-05-31
CY1107841T1 (el)	2013-06-19
ZA200401977B (en)	2006-05-31
CA2460574A1 (en)	2003-04-24
KR20050037409A (ko)	2005-04-21
ECSP024342A (es)	2003-03-10
PL415001A1 (pl)	2016-02-29
CO5390076A1 (es)	2004-04-30
EP1438040B1 (de)	2007-09-26
BR0213355A (pt)	2006-05-23

Legal Events

Date

Code

Title

Description

2008-03-15

UEP

Publication of translation of european patent specification

Ref document number: 1438040

Country of ref document: EP

Publication	Publication Date	Title
DE60222687D1 (de)	2007-11-08	Pharmazeutische zusammensetzungen enthaltend mycophenolsäure oder ein mycophenolat salz
DE50212273D1 (de)	2008-06-26	Pharmazeutische salze von 1-phenyl-3-dimethylamino-propan-verbindungen
DK1399153T3 (da)	2008-01-07	Farmaceutisk præparat indeholdende orlistat og en fedtsyre eller et salt deraf
ATE359064T1 (de)	2007-05-15	Pharmazeutische tramadolsalze
NO2014021I1 (no)	2014-08-20	Bedaquiline eller et farmasøytisk akseptabelt syre- eller baseaddisjonssalt derav
NO2014011I2 (no)	2015-08-31	Vortioksetin eller et farmasøytisk akseptabelt syreaddisjonssalt dera
EP1603593A4 (de)	2007-08-01	Pharmazeutische zusammensetzung
EP1425019A4 (de)	2004-11-17	Pharmazeutische zusammensetzung
ATE320244T1 (de)	2006-04-15	Pharmazeutische zusammensetzungen mit amlodipinmaleat
ATE401908T1 (de)	2008-08-15	Pharmazeutische zusammensetzungen von erythropoietin
ATE367152T1 (de)	2007-08-15	Herstellungsverfahren für niedrig dosierte pharmazeutische zusammensetzung
DE60211183D1 (de)	2006-06-08	Pharmazeutische zusammensetzung enthaltend lumiracoxib
ITMI20011637A0 (it)	2001-07-27	Composizione farmaceutica contenente citalopram
ATE350016T1 (de)	2007-01-15	Bicalutamid enthaltende pharmazeutische zusammensetzung
ATE294804T1 (de)	2005-05-15	Pharmazeutische zusammensetzung enthaltend ein farnesyl-transferase hemmenden 1,2-annellierten chinolin enantiomer
PT1212336E (pt)	2004-04-30	Aglomerados esfericos de telitromicina seu procedimento de preparacao e sua aplicacao na preparacao de formas farmaceuticas
DE10291905D2 (de)	2004-05-27	Pharmazeutische Zusammensetzung
ATE350029T1 (de)	2007-01-15	Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain
IS7581A (is)	2004-12-03	Lyfjasamsetning
DE602005013066D1 (de)	2009-04-16	Ein salz von mirtazapin enthaltende pharmazeutische zusammensetzung
ATE330623T1 (de)	2006-07-15	Stabile pharmazeutische zusammensetzung mit erythropoietin
NO20033073D0 (no)	2003-07-04	Farmasöytisk sammensetning inneholdende citalopram
EE200300378A (et)	2003-10-15	Farmatseutiline kompositsioon
FI20012242A0 (fi)	2001-11-19	Uudet farmaseuttiset yhdisteet
ITMI20011457A0 (it)	2001-07-09	Composizione farmaceutica a rilascio modificato contenente bupropionehc1 come sostanza attiva